MYC and hepatocellular carcinoma: Our results showed that patients with HCC with the best prognosis had low TGF-β1 and high c-Myc expression (3-year OS and DFS rates of 92.6% and 81.5%, respectively), while the worst prognosis was seen in patients who have high TGF-β1 and low c-Myc expression (3-year OS and DFS rates of 11.5% and 3.8%, respectively).